BSF Medical Supplies Tender India 2025: Eye Drops, Cannula, IV Sets, Catheters & More - ISI/ISO Standards 2025

Tender Overview

The procurement is issued by the Border Security Force (BSF) under the Central Armed Police Forces for a broad range of medical consumables and instruments. The estimated value is ₹75,000.00, with a total of 24 items in the BOQ including LIQ BETADINE 500 ML, Betadine 100 ML, EYE DROPS CIPLOX and CIPLOX-D, Cannula 20G/22G, IV Set, Inj Mannitol, Inj Epitoin, Inj Calcium Gluconate, Foley Catheter, ECG Rolls, Respules Duolin/Budocart, Eye Jelly, Sterile/Non-Sterile Gloves (pack of 100), Probiotic Darolac, Vertin 16, EYEDROP TEAR REFRESH, Sat Isabgol, and SOLUTION LOOZ 200 ML. The location is not specified; procurement targets government medical supply needs, with an emphasis on compliance with standard medical packaging and safe handling. A key differentiator is the inclusion of a 25% option clause for quantity variation during the contract term. This tender requires bidders to consider flexible delivery planning and pricing under contracted rates.

Key takeaway for bidders: prepare for a multi-item medical supply basket with varied unit types and ensure capability to deliver across potential extended windows, leveraging the option clause to adjust orders up to 25%.

Technical Specifications & Requirements

• The tender lists a diverse catalog of medical products; no explicit technical specs are provided in the data. Items include pharmaceuticals (Eye Drops, Mannitol, Epitoin, Calcium Gluconate), parenteral components (Cannula 20G/22G, IV Sets, Foley Catheter), disposables (Gloves packs 100, ECG Rolls, Eye Jelly), and aids (Respules Duolin, Budocart, Probiotic Darolac, Isabgol, Tears solution). The BOQ comprises 24 items with unspecified quantities. The estimated contract value is ₹75,000.00. The buyer’s terms allow a 25% quantity variation at contract placement and during the currency of the contract. Bidders should ensure compliance with general safety, sterility, and packaging expectations for medical supplies and be prepared for potential delivery extensions if quantities increase.

• Critical follow-up: verify any implicit standards for pharmaceutical quality, sterility, and packaging, and be prepared to supply OEM authorizations or certifications if requested.

Terms, Conditions & Eligibility

• EMD: not disclosed in the data; bidders should verify during bid submission.
• Delivery terms: delivery period may be influenced by the option clause; extended delivery time calculations are defined by the formula provided (minimum 30 days).
• Payment terms: not specified in the data; bidders should confirm with the procuring agency.
• Documents: typical submission includes GST certificate, PAN, experience certificates, financial statements, EMD documents, technical compliance, and OEM authorizations where applicable.
• BOQ specifics: 24 items with N/A quantities in the provided data; bidders must align报价 with the final purchase order and adapt to 25% quantity variation.
• Clauses: generic option clause requires adherence to quantity adjustments and extended delivery periods as described.